Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Ann Skeet is the Senior Director of Leadership Ethics at the Markkula Center of Applied Ethics. Views are her own. Ethical leadership creates an environment where the goals and values of people ...
The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...
Practices at Lenovo Center are NOT open to the general public unless otherwise communicated. Practices at Invisalign Arena at Wake Competition Center ARE open to the public. No outside food or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results